[go: up one dir, main page]

WO2006121855A2 - Anastomose veineuse mesenterique transcave et systeme d'acces - Google Patents

Anastomose veineuse mesenterique transcave et systeme d'acces Download PDF

Info

Publication number
WO2006121855A2
WO2006121855A2 PCT/US2006/017405 US2006017405W WO2006121855A2 WO 2006121855 A2 WO2006121855 A2 WO 2006121855A2 US 2006017405 W US2006017405 W US 2006017405W WO 2006121855 A2 WO2006121855 A2 WO 2006121855A2
Authority
WO
WIPO (PCT)
Prior art keywords
flange part
anastomosis
anastomosis device
catheter
lumen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/017405
Other languages
English (en)
Other versions
WO2006121855A3 (fr
Inventor
Aravind Arepally
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Priority to US11/919,870 priority Critical patent/US20100106171A1/en
Publication of WO2006121855A2 publication Critical patent/WO2006121855A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006121855A3 publication Critical patent/WO2006121855A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3498—Valves therefor, e.g. flapper valves, slide valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1103—Approximator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis for blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
    • A61B2017/1139—Side-to-side connections, e.g. shunt or X-connections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22072—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
    • A61B2017/22074—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel
    • A61B2017/22077—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel with a part piercing the tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI

Definitions

  • the present invention generally relates to devices and systems for percutaneously forming an anastomosis between two vascular lumens or two anatomical chambers, wherein one of the lumens or chambers is not directly accessible by conventional percutaneous interventional procedures. More particularly, the present invention relates to devices and systems for forming an anastomosis between the inferior vena cava (IVC) and the portal vein of the mesenteric venous system, whereby the anastomosis enables periodic and relatively easy access to the mesenteric venous system.
  • IVC inferior vena cava
  • Islet cell transplantation has shown great promise for treating diabetes as an alternative to insulin injection. Islet cell transplantation involves the direct injection of islet cells into the portal vein of a patent's liver. Successful implementation of islet cell transplantation requires periodic direct access to the portal vein and liver.
  • liver cancer is on the rise in the U.S. It is estimated that there will be 18,500 new cases of primary liver cancer diagnosed in the U.S. in 2006. Pancreatic cancer, the fifth leading cause of cancer death in the U.S., is diagnosed in more than 29,000 people in the U.S. every year. Successful treatment of liver and pancreatic cancers would be greatly enabled by the ability to directly introduce therapeutic agents.
  • liver cirrhosis is a consequence of liver disease, in which healthy tissue is replaced by scar tissue. Cirrhosis generally leads to portal hypertension, in which liver scar tissue prevents blood flow through the liver, which in turn increases blood pressure in the portal system. Left unchecked, portal hypertension may cause abdominal swelling, damage other organs in the portal system, and may cause fatal bleeding.
  • the TIPS procedure is generally performed without direct visualization of the portal venous system, which may incur complications such as traversal of the liver capsule and creation of fistulous tracts from the shunt to the hepatic artery of bile ducts.
  • the inherent difficulty of creating portosystemic and TIP shunts precludes less invasive procedures, such as percutaneous procedures.
  • liver cancer pancreatic cancer
  • diabetes via islet cell transplantation
  • islet cell transplantation are difficult because they require access the mesenteric venous system directly through the liver. This has risks of complications. Further, related art treatments only allow temporary access to the mesenteric system.
  • the present invention provides a transcaval mesenteric venous anastomosis and access system that obviates one or more of the aforementioned problems due to the limitations of the related art.
  • the present invention provides this by creating an anastomosis between the IVC and the portal vein, wherein the anastomosis may provide temporary and on-demand percutaneous access to the mesenteric venous system, which is otherwise not accessible by the related art percutaneous techniques.
  • one advantage of the present invention is that it enables safe and repeated access to the mesenteric system.
  • Another advantage of the present invention is that it provides a safe, more effective treatment for portal hypertension.
  • a device for creating an anastomosis between two vascular lumens which comprises a first flange part; a second flange part; a flow lumen part disposed between the first flange part and the second flange part; and a valve part disposed on the first flange part.
  • the aforementioned and other advantages are achieved by a device for creating an anastomosis between two vascular lumens, which comprises a first flange part; a second flange part; and a flow lumen part disposed between the first flange part and the second flange part, wherein the first flange part, the second flange part, and the flow lumen part include a wire having a memory shape material.
  • the aforementioned and other advantages are achieved by a method for creating an anastomosis between a first and a second vascular lumen.
  • the method comprises inserting a catheter into the first vascular lumen; guiding the catheter to a desired location for the anastomosis; puncturing the first vascular lumen; puncturing the second vascular lumen; inserting the catheter into the second vascular lumen; deploying a distal flange part of an anastomosis device within the second vascular lumen; bringing the second vascular lumen into apposition with the first vascular lumen; and deploying a proximal flange part of the anastomosis device within the first vascular lumen.
  • FIG. IA illustrates an exemplary anastomosis device according to a first embodiment of the present invention
  • FIG. IB is a plan view of the exemplary anastomosis device of FIG. IA;
  • FIG. 1C illustrates a wire structure of the exemplary anastomosis device of FIG. IA
  • FIG. ID illustrates exemplary dimensions corresponding to the wire structure of FIG. 1C;
  • FIG. IE illustrates an exemplary anastomosis device having a plurality of capacitors;
  • FIG. IF illustrates a wire structure of the exemplary anastomosis device of FIG. IE
  • FIG. 2A illustrates an exemplary anastomosis device according to a second embodiment of the present invention
  • FIG. 2B is a plan view of the exemplary anastomosis device of FIG. 2A;
  • FIG. 3 A is a cutaway view of an exemplary insertion catheter according to the present invention.
  • FIG. 3B illustrates an exemplary insertion catheter having RF antennas for visualization under MRI
  • FIG. 4 illustrates an exemplary process for deploying the anastomosis device according to the present invention.
  • FIGs. 5A-E illustrate an exemplary process for inserting and deploying an anastomosis device according to the present invention. DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
  • the present invention involves a device for percutaneously bringing two vascular lumens into apposition and creating an anastomosis between the two vascular lumens.
  • the anastomosis device may enable flow between the two vascular lumens, or the anastomosis device may keep the two vascular lumens isolated from each other to maintain the naturally present conditions.
  • the anastomosis device provides an access point for repeated percutaneous access to an otherwise isolated or inaccessible vascular lumen.
  • the anastomosis device provides a safe access point for advancing interventional devices, under x-ray, MRI or CT imaging guidance, for the purpose of delivering, for example, a therapeutic or a diagnostic device to the vascular lumen.
  • the term "vascular lumen" may refer an artery, a vein, an anatomical chamber, or the like.
  • the anastomosis device may have a valve structure for nominally sealing the anastomosis created by the device, which may enable periodic percutaneous access between the two vascular lumens.
  • the valve structure on the anastomosis device may be nominally closed so that the IVC and the mesenteric portal vein may be nominally isolated.
  • the valve structure has sufficient flexibility to enable a needle or an interventional device to pass through the anastomosis for the purposes of injecting therapeutic agents directly into the organ being treated (e.g., the liver or the pancreas).
  • the valve structure on the anastomosis device may have a predetermined rigidity such that, if a pressure differential between the IVC and the mesenteric portal vein increases beyond a certain threshold, the valve will temporarily open to alleviate the pressure differential.
  • the valve structure enables the routing of blood from the mesenteric system into the IVC, thus decompressing the portal system and maintaining a naturally occurring pressure gradient between the two vessels, hi doing so, blood is routed through the liver, thus utilizing the functionality of the liver.
  • the valve structure may not be present.
  • FIG. IA illustrates an anastomosis device 100 according to a first embodiment of the present invention.
  • Anastmosis device 100 includes a proximal flange part 110, a distal flange part 120, and a flow lumen part 130 between proximal flange part 110 and distal flange part 120.
  • Proximal flange part 110 has a plurality of proximal radial struts 115a-f
  • distal flange part 120 has a plurality of distal radial struts 125a-f.
  • a valve part 140 Disposed on the plurality of proximal radial struts 115a-f is a valve part 140, which may include a plurality of leaflet parts 140a-c.
  • Proximal flange part 110 and distal flange part 120 are used to hold the vascular lumens apposed to each other, as illustrated in greater detail below.
  • Flow lumen part 130 provides a flow conduit for blood (or other fluids) and provides a path for a surgeon to advance an interventional diagnostic or therapeutic device.
  • Proximal radial struts 115a-f define an aperture (not shown) in a center portion of proximal flange part 110.
  • Distal radial struts 125a-f define a similar aperture in a center portion of distal flange part 120.
  • Flow lumen part 130 defines a cylinder-like path corresponding to the respective apertures of proximal flange part 110 and distal flange part 120.
  • Proximal radial struts 115a-f, distal radial struts 125a-f, and flow lumen part 130 may be formed by a wire 150.
  • Wire 150 may include a memory shape material, such as Nitinol.
  • the term "wire” will be used, but it will be readily apparent to one skilled in the art that "wire” may refer to a plurality of wires.
  • Wire 150 may have a substantially cylindrical cross section, or may have a cross section of different shapes.
  • Wire 150 may have a diameter of about 0.009".
  • anastomosis device 100 provides sufficient mechanical holding force to maintain the two vascular lumens in apposition.
  • FIG. 1C illustrates exemplary anastomosis device 100, in which the valve part 140 is not present.
  • the wire structure of anastomosis device 100 may include a single strand of wire 150, which is manipulated to form proximal radial struts 115a-f, distal radial struts 125a-f, and flow lumen part 130.
  • FIG. ID is a plan view of the wire structure of FIG. 1C.
  • the outer and inner circles of FIG. ID are for illustrating diameters and are not necessarily part of the wire structure of anastomosis device 100.
  • aperture 155 may have a diameter 160 of about 6 mm.
  • Proximal and distal radial struts 115a-f and 125a-f may have a length 165 of about 6 mm.
  • the outer diameter 170 of the Proximal and distal flange parts 110 and 120 may be about 18 mm, and may be in a range between about 1 cm to about 3 cm.
  • proximal and distal components of anastomosis device need not be the same for the proximal and distal components of anastomosis device; the proximal flange part 110 and the distal flange part 120 may have different dimensions, depending on the vascular lumens in which the anastomosis is to be formed.
  • Flow lumen part 130 may have a length 175 of about 3 mm. Other values for length 175 are possible and within the scope of the invention, depending on the thicknesses of the walls of the vascular lumens in which the anastomosis is to be formed.
  • Flow lumen part 130 may have a substantially straight cylindrical shape, as illustrated in FIG. 1C, or it may have a substantially toroidal shape such that wire 150 forming flow lumen part 130 may have a substantially continuous curvature between proximal flange part 110 and distal flange part 120.
  • a substantially toroidal curvature in flow lumen part 130 may help maintain pressure between the two vascular lumens in which the anastomosis is to be formed. In doing so, the two vascular lumens may be kept in apposition.
  • the first embodiment of the present invention may include six proximal radial struts 115a-f and six distal radial struts 125a-f. A greater or lesser number of radial struts are possible and within the scope of the invention.
  • the preferred number of radial struts, the length 165 of the radial struts 115a-f and 125a-f, the diameter 160 of aperture 155, and the length 175 of flow lumen part 130 may vary. These parameter may depend on factors such as the diameter of the anastomosis to be formed, the required stability of the anastomosis, the rigidity, strength, and the thickness of the walls of the vascular lumens in which the anastomosis is to be formed.
  • valve part 140 may have leaflets 140a-c, as stated above.
  • Leaflets 140a-c may be adhered to wire 150 of proximal radial struts 115a-f.
  • Leaflets 140a-c may be made of teflon, dacron, PVDF (polyvinylidine diflouride), PVA (polyvinyl acetate), an ultra thin membrane of Nitinol, or the like.
  • Leaflets 140a-c may have a thickness sufficient to prevent flow through flow lumen part 130 when the pressure differential between the two vascular lumens, in which the anastomosis is formed, is below a specified pressure differential.
  • valve leaflets 140a-c should have a sufficient thickness so that the valve is sufficiently strong to prevent flow through the anastomosis under nominal pressure differential conditions. However, valve leaflets 140a-c should not be so thick that it would make it difficult to penetrate valve part 140 with a diagnostic or therapeutic device from the IVC. The desired thickness may depend on the material in leaflets 140a-c.
  • FIG. IA illustrates valve part 140 disposed on proximal flange part 110, one skilled in the art will realize that valve part 140 may be formed alternatively, or additionally, on distal flange part 120.
  • valve part 140 is to be disposed on proximal flange part 110, distal flange part 120, or both, will depend on the intended use of anastomosis device 110, e.g., alleviation of portal hypertension, delivery of therapeutic agents, etc.
  • FIG. IB illustrates leaflets 140a-c as being three separate pieces of material
  • leaflets 140a-c may be formed from one piece of material. If one piece of material is used, then leaflets 140a-c may be created by cutting one or more slits in the material to form a valve. Further, although FIG. IB illustrates three leaflets 140a-c, a greater number or lesser number of leaflets may be used to form valve part 140. Factors to consider in when varying the design of valve part 140 include the strength of the valve part 140, the ease with which valve part 140 is to be penetrated for injecting therapeutic agents, and how easily valve part 140 should collapse so that it can be inserted into a catheter (discussed below).
  • FIGs. IE and IF illustrate a variation of anastomosis device 100, which has a plurality of capacitors 180.
  • Capacitors 180 may have a capacitance to tune the structure of wire 150 to the larmor frequency of MRI (1 or more field strengths).
  • anastomosis device 100 may function as an RF antenna, in which anastomosis device 100 inductively couples to the surface RF transmit and receive coils used in MRI. This may make anastomosis device 100 visible in MR imagery, which may enable MRI guided implantation and monitoring of anastomosis device 100.
  • FIGs. 2A and 2B illustrate an exemplary anastomosis device 200 according to a second embodiment of the present invention.
  • Exemplary anastomosis device 200 may be substantially similar to anastomosis device 100, but with a different valve part 240.
  • Anastomosis device 200 may also have a plurality of capacitors (not shown) substantially similar to capacitors 180 of anastomosis device 100.
  • Valve part 240 includes a spiral configuration of wire, such as Nitinol. More specifically, valve part 240 may have a superelastic coil that forms a seal.
  • Valve part 240 is preferably disposed on the proximal flange part 210, the distal flange part 220, or both, as explained above.
  • valve part 240 is disposed on proximal flange part 210, the proximal radial struts 215a-f may have a covering substantially similar to leaflets 140a-c of the first embodiment. The covering is to prevent leakage around valve part 240. Similarly, if valve part 240 is disposed on distal flange part 220, then distal radial struts 225a-f may have a covering.
  • valve part 140/240 may be disposed within flow lumen part 130/230.
  • valve part 140/240 may be attached to the radial struts of the proximal flange part 110/210 and the distal flange part 120/220.
  • FIG. 3 A is a cutaway view of an exemplary catheter 300 for deploying anastomosis device 100/200 according to the present invention.
  • Catheter 300 preferably includes the following: a needle 310; an inner sheath 320 substantially covering needle 310; an outer sheath 330, which encompasses a folded anastomosis device 100/200; and an outer flange part 340.
  • Inner sheath 320 serves as a lumen for needle 310. It may also serve as a guide wire for catheter 300.
  • Outer sheath 330 contains anastomosis device 100/200 in a folded or collapsed configuration to minimize its diameter for delivery through the walls of the vascular lumens in which it will be deployed (described below).
  • Outer sheath 330 may be a sheath that an operator can gradually pull to separate it from anastomosis device 100/200 to deploy the device.
  • outer sheath 330 may include a fiber weave crimping/delivery device, which has a knit cord encasing anastomosis device 100/200. The knit cord may be unraveled by the operator to deploy anastomosis device 100/200.
  • Outer flange part 340 may have one or more radial protrusions for preventing separation of the two vascular lumens during deployment of anastomosis device 100/200. This will be described further below.
  • FIG. 3B illustrates an exemplary catheter 300 having one or more radio frequency (RF) antennas 350 disposed at its tip and along its length.
  • RF antennas 350 provide for visibility under MRI and thus enable deployment of the anastamosis device using MRI guidance.
  • RF antennas 350 include tuning circuitry (not shown) to match their respective resonant frequencies of the MRI larmor frequency. In doing so, catheter 300 may be visible along its length under MRI, which will provide MR imagery-based guidance to the surgeon deploying anastomosis device 100/200 according to the present invention.
  • a description of the RF antennas 350 is disclosed in International Patent Application No. PCT/US2005/017351, Publication No. WO 2005/112836 A2, titled INTERVENTIONAL DEVICES FOR CHRONIC TOTAL OCCLUSION RECANALIZATION UNDER MRI GUIDANCE, which is hereby incorporated by reference as if fully disclosed herein.
  • FIG. 4 illustrates an exemplary process 400 for deploying anastomosis device 100/200 according to the present invention.
  • the description below pertains to creating an anastomosis between the IVC 510 and the mesenteric portal vein 520.
  • process 400, along with catheter 300 and anastomosis device 100/200 may be modified to be suitable for other parts of the anatomy e.g. as an atrial septal closure device to be implanted at the patent fossa ovalis.
  • process 400, catheter 300, and anastomosis device 100/200 could be modified to perform other procedures, such as Pulmonary Artery to Subclavian Artery bypass for congenital heart disease; Pulmonary Artery to Aorta bypass for congenital heart disease; Inferior Vena Cava to Splenic Vein for Spleno- Renal Shunt for portal hypertension and venous therapies to the spleen; and Renal vein to Splenic Vein for portal hypertension and venous therapies to the spleen. All such variations are possible and within the scope of the invention.
  • catheter 300 is inserted into IVC 510 and guided to the location where an anastomosis is to be formed.
  • step 415 the wall of IVC 510 is punctured with needle 310 of catheter 300.
  • step 420 catheter 300 is inserted through the wall of IVC 510, and then the wall of portal vein 520 is punctured by needle 310.
  • distal flange part 120/220 is deployed within portal vein 520.
  • This can be done several ways. According to one way, once the distal end of folded anastomosis device 100/200 is within portal vein 520, outer sheath 330 of catheter 300 is pulled back until distal flange part 120/220 is exposed. Being made of a shape memory material, distal flange part 120/220 opens to take its shape as illustrated in FIGs. IA and 2A. Alternatively, if outer sheath 330 has a fiber weave crimping/delivery device, a line of the fiber weave device is pulled to unravel the delivery device. As the delivery device unravels, distal flange part 120/220 opens up to take its shape illustrated in FIGs. IA and 2A.
  • catheter 300 is pulled back to bring portal vein 520 into apposition with IVC 510.
  • outer flange part 340 is held against the wall of IVC 510 to prevent IVC 510 from retreating from portal vein 520 as catheter 300 is drawn back.
  • Catheter 300 may include other mechanisms (not shown), such as an inflatable balloon, a collapsible stent, or an additional sheath. These additional mechanisms may further enable apposition of IVC 510 and portal vein 520 in step 430. Any of these additional mechanisms may be used to help push portal vein 520 toward IVC 510.
  • proximal flange part 110/210 of anastomosis device 100/200 is deployed within IVC 510.
  • outer sheath 330 is pulled back to expose proximal flange part 110/210.
  • the line of the fiber weave is pulled further to unravel the delivery device and expose proximal flange part 110/210.
  • proximal flange part 110/210 Once proximal flange part 110/210 is exposed, it opens (in a manner similar to distal flange part 120/220) to take its shape as illustrated in FIGs. IA and 2A.
  • proximal flange part 110/210 engages the wall of IVC 510 and holds it in apposition to the wall of portal vein 520.
  • an anastomosis is created by anastomosis device 100/200 between IVC 510 and portal vein 520.
  • the anastomosis is illustrated as being used for alleviating portal hypertension.
  • Anastomosis device 100/200 having valve part 140/240, enables safer and repeated access to the mesenteric system via the IVC to deliver diagnostic and therapeutic devices, drugs, cellular therapies to mesenteric system organs, such as the liver, pancreas, and spleen.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention concerne un système permettant de créer une anastomose entre la veine cave inférieure (IVC) et la veine porte mésentérique. Ce système comprend un dispositif d'anastomose et un cathéter. Le dispositif d'anastomose permet de mettre la veine cave inférieure et la veine porte en apposition. L'anastomose résultante permet de traiter l'hypertension portale et assure en outre un accès répété et aisé au système portal afin de permettre l'apport direct d'agents thérapeutiques dans les organes portaux. Le dispositif d'anastomose comporte une collerette proximale, une collerette distale, et une lumière d'écoulement formée entre les collerettes. Les collerettes proximale et distale comprennent une pluralité de montants radiaux. Une système de soupape est installé sur la collerette proximale et/ou sur la collerette distale. Ce dispositif d'anastomose est composé d'un matériau à mémoire de forme. Le cathéter contient un dispositif d'anastomose replié à introduire, et comprend une ou plusieurs antennes RF permettant la visualisation du cathéter lors du guidage par IRM.
PCT/US2006/017405 2005-05-06 2006-05-05 Anastomose veineuse mesenterique transcave et systeme d'acces Ceased WO2006121855A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/919,870 US20100106171A1 (en) 2005-05-06 2006-05-05 Transcaval mesenteric venous anastomosis and access system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67833905P 2005-05-06 2005-05-06
US60/678,339 2005-05-06

Publications (2)

Publication Number Publication Date
WO2006121855A2 true WO2006121855A2 (fr) 2006-11-16
WO2006121855A3 WO2006121855A3 (fr) 2008-11-06

Family

ID=37397125

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/017405 Ceased WO2006121855A2 (fr) 2005-05-06 2006-05-05 Anastomose veineuse mesenterique transcave et systeme d'acces

Country Status (2)

Country Link
US (1) US20100106171A1 (fr)
WO (1) WO2006121855A2 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124314A1 (fr) 2007-04-04 2008-10-16 Rox Medical, Inc. Dispositif et procédé de mise en place d'une fistule artério-veineuse artificielle
WO2010151382A1 (fr) * 2009-06-26 2010-12-29 Wilson-Cook Medical Inc. Pinces linéaires pour anastomose
RU2410038C1 (ru) * 2009-11-23 2011-01-27 Шамиль Ханафиевич Ганцев Способ портокавального шунтирования при циррозе печени с синдромом портальной гипертензии
US20110118765A1 (en) * 2009-11-18 2011-05-19 Aguirre Andres F Anastomosis stent
US8088171B2 (en) 2004-08-27 2012-01-03 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8657853B2 (en) 2009-06-02 2014-02-25 Ethicon, Inc. Incision closure device and method
US8932341B2 (en) 2004-08-27 2015-01-13 Rox Medical, Inc. Method for establishing an artificial arterio-venous fistula
EP3349687A4 (fr) * 2015-09-15 2019-06-26 THE UNITED STATES OF AMERICA, represented by the S Dispositifs et des procédés permettant de réaliser des opérations glenn et fontan percutanées
EP3622899A1 (fr) * 2014-05-02 2020-03-18 W. L. Gore & Associates Inc Dispositifs d'anastomose
US11364374B2 (en) 2016-03-30 2022-06-21 Heartware, Inc. Flanged heart tissue blocker
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US12376956B2 (en) 2017-09-01 2025-08-05 Transmural Systems Llc Percutaneous shunt devices and related methods

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2454957C1 (ru) * 2011-02-24 2012-07-10 Вячеслав Леонидович Коробка Способ хирургического лечения хронического панкреатита, осложненного тромбозом воротной вены
RU2463972C1 (ru) * 2011-03-04 2012-10-20 Вячеслав Леонидович Коробка Способ выбора тактики хирургического лечения хронического панкреатита, осложненного тромбозом воротной вены
EP2683341B1 (fr) 2011-03-08 2015-12-30 W.L. Gore & Associates, Inc. Dispositif médical pour utilisation avec un stomate
US9554801B2 (en) 2014-03-14 2017-01-31 Cook Medical Technologies Llc Extravascular implant for facilitating sutured side-to-side arteriovenous fistula creation and maintaining patency
EP3025652A1 (fr) * 2014-11-28 2016-06-01 Luc Joyeux Dispositif biomédical pour scellement étanche d'une ouverture
WO2018002933A1 (fr) * 2016-06-30 2018-01-04 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Appareil et procédé pour accéder à l'aorte
CN106821544B (zh) * 2016-12-14 2019-03-12 闫盛 一种人工血管系统
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
CN114568015A (zh) 2019-08-22 2022-05-31 爱德华兹生命科学公司 穿刺针
CR20220218A (es) 2019-11-14 2022-08-22 Edwards Lifesciences Corp Colocación transcatéter de implante médico
RU2743730C1 (ru) * 2020-06-17 2021-02-25 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии" Министерства здравоохранения Российской Федерации Способ корпорокаудальной резекции поджелудочной железы при злокачественных опухолях тела поджелудочной железы с опухолевой инвазией устья селезеночной вены
US12527942B2 (en) 2021-02-01 2026-01-20 Edwards Lifesciences Corporation Pulmonary vein shunting
EP4554480A1 (fr) 2022-07-12 2025-05-21 Katholieke Universiteit Leuven Dispositif et procédé de fermeture d'une ouverture d'une paroi corporelle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016883A (en) * 1975-11-11 1977-04-12 Wright Jr Sanford J Medical clamp for occluding intracranial blood vessels
US6695810B2 (en) * 1997-11-21 2004-02-24 Advanced Interventional Technologies, Inc. Endolumenal aortic isolation assembly and method
US6790229B1 (en) * 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US6458140B2 (en) * 1999-07-28 2002-10-01 Vasconnect, Inc. Devices and methods for interconnecting vessels
DE60334313D1 (de) * 2002-11-19 2010-11-04 J Donald Hill System und vorrichtung zum durchführen von minimal invasiver koronarer arterienbypassimplantation

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8523800B2 (en) 2004-08-27 2013-09-03 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US10751057B2 (en) 2004-08-27 2020-08-25 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US10098643B2 (en) 2004-08-27 2018-10-16 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9820745B2 (en) 2004-08-27 2017-11-21 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8088171B2 (en) 2004-08-27 2012-01-03 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9510832B2 (en) 2004-08-27 2016-12-06 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9706997B2 (en) 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8734472B2 (en) 2004-08-27 2014-05-27 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8932341B2 (en) 2004-08-27 2015-01-13 Rox Medical, Inc. Method for establishing an artificial arterio-venous fistula
US9023097B2 (en) 2004-08-27 2015-05-05 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9468441B2 (en) 2004-08-27 2016-10-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
EP2136734A4 (fr) * 2007-04-04 2011-06-08 Rox Medical Inc Dispositif et procédé de mise en place d'une fistule artério-veineuse artificielle
WO2008124314A1 (fr) 2007-04-04 2008-10-16 Rox Medical, Inc. Dispositif et procédé de mise en place d'une fistule artério-veineuse artificielle
US8657853B2 (en) 2009-06-02 2014-02-25 Ethicon, Inc. Incision closure device and method
WO2010151382A1 (fr) * 2009-06-26 2010-12-29 Wilson-Cook Medical Inc. Pinces linéaires pour anastomose
AU2010263224B2 (en) * 2009-06-26 2014-02-06 Cook Medical Technologies Llc Linear clamps for anastomosis
US20110118765A1 (en) * 2009-11-18 2011-05-19 Aguirre Andres F Anastomosis stent
RU2410038C1 (ru) * 2009-11-23 2011-01-27 Шамиль Ханафиевич Ганцев Способ портокавального шунтирования при циррозе печени с синдромом портальной гипертензии
US11596409B2 (en) 2014-05-02 2023-03-07 W.L. Gore & Associates, Inc. Anastomosis devices
US12232732B2 (en) 2014-05-02 2025-02-25 W. L. Gore & Associates, Inc. Anastomosis devices
US12478362B2 (en) 2014-05-02 2025-11-25 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US12478376B2 (en) 2014-05-02 2025-11-25 W. L. Gore & Associates, Inc. Anastomosis devices
US12303132B2 (en) 2014-05-02 2025-05-20 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US12268392B2 (en) 2014-05-02 2025-04-08 W. L. Gore & Associates, Inc. Anastomosis devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11980367B2 (en) 2014-05-02 2024-05-14 W. L. Gore & Associates, Inc. Anastomosis devices
US12023031B2 (en) 2014-05-02 2024-07-02 W. L. Gore & Associates, Inc. Anastomosis devices
EP3622899A1 (fr) * 2014-05-02 2020-03-18 W. L. Gore & Associates Inc Dispositifs d'anastomose
EP3349687A4 (fr) * 2015-09-15 2019-06-26 THE UNITED STATES OF AMERICA, represented by the S Dispositifs et des procédés permettant de réaliser des opérations glenn et fontan percutanées
US11179156B2 (en) 2015-09-15 2021-11-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Devices and methods for effectuating percutaneous glenn and fontan procedures
US10426482B2 (en) 2015-09-15 2019-10-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Devices and methods for effectuating percutaneous Glenn and Fontan procedures
US11364374B2 (en) 2016-03-30 2022-06-21 Heartware, Inc. Flanged heart tissue blocker
US12376956B2 (en) 2017-09-01 2025-08-05 Transmural Systems Llc Percutaneous shunt devices and related methods

Also Published As

Publication number Publication date
WO2006121855A3 (fr) 2008-11-06
US20100106171A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
US20100106171A1 (en) Transcaval mesenteric venous anastomosis and access system
US20220008186A1 (en) Embolic protection device
US5895404A (en) Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel
US9861728B2 (en) Heart assist system and methods
WO2020081597A1 (fr) Systèmes et procédés d'accès et de distribution par perforation magnétique
JP6637430B2 (ja) 血管内脳脊髄液シャント
US11413043B2 (en) Anchor device for vascular anastomosis
WO2008027869A2 (fr) Dispositifs, methodes et systemes permettant d'etablir un flux sanguin supplementaire dans le systeme circulatoire
CA2700849A1 (fr) Applicateur, assemblage et procede servant a connecter un conduit d'admission a un organe creux
CN109789255A (zh) 用于递送体内装置的经导管装置及系统
US20230346536A1 (en) Methods and systems for placing embolic filters in an aortic arch
EP4321186B1 (fr) Dispositifs d'hémodialyse sans fistule
US20140222066A1 (en) Extra-vascular closure device with releasable sealing plug
US20140194918A1 (en) Rapid exchange temporary blood flow cessation device for large bore closure
US20070010781A1 (en) Implantable aorto-coronary sinus shunt for myocardial revascularization
US20190216603A1 (en) Apparatus and method for accessing aorta
CN117503445A (zh) 推送导管和经血管植入物输送装置
US20250128030A1 (en) Systems and methods for creating an access path between blood vessels
CN117338352A (zh) 医用装置及医疗系统
US20070010780A1 (en) Methods of implanting an aorto-coronary sinus shunt for myocardial revascularization
CN118986602A (zh) 支架、内导管、输送组件以及输送装置
WO2007002616A2 (fr) Shunt implantable entre l'aorte et le sinus coronaire pour revasculariser le myocarde et methode d'utilisation de ce shunt
IES85716Y1 (en) An angioplasty assembly

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06770034

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)